Stockreport

BRIEF-Aviragen Therapeutics Comments on ISS Report [Reuters]

Atea Pharmaceuticals, Inc. - common stock  (AVIR) 
PDF BRIEF-Aviragen Therapeutics Comments on ISS Report | Reuters Reuters Staff 1 Min Read Jan 26 (Reuters) - Aviragen Therapeutics Inc: * AVIRAGEN THERAPEUTICS - ISSUED STAT [Read more]